1. Market Research
  2. > Pharmaceutical
  3. > Drug Delivery Market Trends
Pharmaceutical Excipients Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product ; Functionality ; Type of Formulation and Geography

Pharmaceutical Excipients Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product ; Functionality ; Type of Formulation and Geography

  • January 2021
  • 172 pages
  • ID: 6027559
  • Format: PDF
  • The Insight Partners

Summary

Table of Contents

Search Inside

The global pharmaceutical excipients market is expected to reach US$ 9,873.53 million by 2027 from US$ 6,521.74 million in 2019. The market is estimated to grow at a CAGR of 5.5% from 2020 to 2027.
Surge in generics market and growth of the pharmaceutical market backed by multi-functional excipients are expected to boost the market growth over the years. However, cost and time intensive drug development process are likely to pose a negative impact on the market growth.
Excipients are an integral component of pharmaceutical products that primarily determine the structure of dosage type and its role in delivering drugs.Excipients significantly affect the process ability, aesthetics, efficiency, and patient compliance with the dosage form.

Thus, the use of excipients in a formulation requires an assurance and a clear understanding of their quality, safety, and performance attributes.The principal role of excipients is to support patient acceptability, enhance stability, bioavailability, and assist in the effectiveness.

The generics industry has witnessed a remarkable run over the last decade, with companies achieving above-average shareholder returns.Generic drugs are the alternatives to branded drugs with the same dosage form, safety, strength, administration route, and quality.

As per stats provided by the India Brand Equity Foundation (IBEF), India is among the largest supplier of generic medicines and the country’s generic medicines account for ~20% of the global exports of generic medicines. In 2017, Indian pharmaceutical companies received 300 generic drug approvals in the US. Thus, the worldwide rise in the sale of generic drugs has increased the demand for prescription excipients. The market consists of revenues made by companies manufacturing pharmaceutical excipients through the sales of these excipients. In addition, many blockbuster drugs are on the brink of losing their patents. The patent cliff has resulted in billions dollars’ worth of brand drug sales losing patent protection. Generic drug companies are free to produce their own replicas when patents expire, which can cost up to 80% less than the originals, eventually resulting in a sharp and sudden loss of profits for the companies that developed them. Use of functionality excipients, allows pharmaceutical firms to extend patents. The need to cut prices, generic competition, and lack of innovation are weighing the pharmaceutical industry down. Excipients have become an integral element in the manufacturing of tablets as these provide improved functionality in pharmaceuticals and aid in drug development and innovation, which, in turn help improve patent life at a lower cost. Excipients play a significant role in helping pharmaceutical manufacturers by increasing treatment effectiveness and compliance.
Product Insights
Based on product, the pharmaceutical excipients market is segmented into organic chemicals, inorganic chemicals, and other products.In 2019, the organic chemicals segment held the largest market share.

This segment is also expected to dominate the market in 2027 owing to the rise in the use of organic chemicals in various formulations in the pharmaceutical industry. Moreover, the same segment is anticipated to grow at the fastest rate during the forecast period.

Functionality Insights
Based on functionality, the pharmaceutical excipients market is segmented into fillers and diluents, suspending and viscosity agents, coating agents, binders, preservatives, emulsifying agents, and other functionalities.In 2019, the fillers and diluents segment held the largest market share in the pharmaceutical excipients market.

This segment is also expected to dominate the market by 2027 as it offers the advantages in the development and production of drugs. Moreover, diluents offer more reliable tablet properties like the improved cohesion promotes proper flow.

Type of Formulation Insights
In terms of type of formulation, the pharmaceutical excipients market is segmented into oral formulations, topical formulations, parenteral formulations, and other formulations.In 2019, the oral formulations segment held the largest market share.

This segment is also expected to dominate the market during the forecast period as oral formulations as it is the most commonly used formulation in pharmaceuticals to treat various disease conditions. Moreover, it is a cost-effective method for the administration of medicine and easy to manufacture compared to other dosage forms.
DuPont de Nemours, Inc.; Roquette Frères; Ashland Global Holdings, Inc.; BASF SE; Evonik Industries AG; Associated British Foods Plc; Archer Daniels Midland Company; Lubrizol Corporation; Croda International Plc; and DFE Pharma are among the major primary and secondary sources for pharmaceutical excipients included in the report.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.

ref:plp2020

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on